Validation of mRNA (CUL2 and RBBP4) expression at the protein level was performed by western blot. MDMs infected with HIV-1/HIV-2 and uninfected controls, cultured for 7 days post infection were collected by scrapping followed by centrifugation. Proteins were extracted with RIPA buffer (Cat # 89901, Thermo Scientific) supplemented with protease inhibitor cocktail (Cat # 4693159001, Sigma-Aldrich). Equal amount of proteins (5 µg) were used in the Western blot experiment as described earlier28 (link) with m CUL 2 monoclonal antibody (Santa Cruz Biotechnology, Inc., Cat # sc-166506)67 (link), RBBP4 monoclonal antibody (Santa Cruz Biotechnology, Inc., Cat # sc-373873)68 (link) and β-Actin monoclonal antibody (Santa Cruz Biotechnology, Inc., Cat # sc-47778)69 (link). ECL western blotting analysis system (Cat # RPN2108, GE Healthcare) was used to visualize the proteins.
Free full text: Click here